What next for the Sacklers? A pharma dynasty under siege | Curio

What next for the Sacklers? A pharma dynasty under siege

19 mins | Sep 12, 2018

They've filed for bankruptcy but haven't garnered any sympathy. We revisit this article explaining why. David Crow writing in the Financial Times unfolds a special report into the scandal of a company accused of fuelling America’s opioid crisis

publisher logo

From Financial Times